The urgent demand for the degradation of per- and polyfluoroalkyl substances (PFAS) in the global water environment has led to numerous technology solutions in the past few decades. The majority of engineering approaches use energetic inputs such as hydrothermal, ultraviolet light, plasma, electricity, ultrasonication, and even gamma ray to cleave the strong C—F bonds. However, certain PFAS compounds are notoriously refractory to chemical degradation and may require high energy input. Current materials and methods used for PFAS defluorination still have various limitations. New and efficient materials and methods are needed.
Certain embodiments of the invention provide a composition comprising:
Certain embodiments of the invention provide a method as described herein.
Certain embodiments of the invention provide a composite or composition as described herein (e.g., metallic particles, and a ligand).
Certain embodiments of the invention provide a method of making a composition as described herein, comprising mixing the zero-valent metal with the ligand (e.g., in an aqueous solution).
Certain embodiments of the invention provide a method for degrading a PFAS compound, comprising contacting the PFAS compound with a composite or composition as described herein.
Certain embodiments of the invention provide a device or system as described herein (e.g., a filtering device comprising the composition as described herein).
New composite, composition, device, system, and/or methods are described herein for PFAS defluorination. It was surprisingly shown herein that organic ligands surprisingly led to reductive defluorination from per- and polyfluoroalkyl substances (PFAS) compounds, including linear Perfluoroalkyl carboxylic acids (PFCAs) and Perfluoroalkyl ether carboxylic acids (PFECAs), by zero valent metal as described herein.
Certain embodiments of the composite, composition, device, system, and methods can be used for in-situ remediation of soil and groundwater from PFAS contamination. For illustrative purposes, the materials and compositions described herein may be used in a permeable reactive barrier installed underground for groundwater remediation. Exemplary application also includes expansion to filter systems for treating water and wastewater streams that contain PFAS. For example, the composite described herein (e.g., Ligand-Zinc composite) can be loaded in the filter system for proactive treatment.
Accordingly, certain embodiments of the invention provide a composition comprising:
In certain embodiments, R9, and R10 are oxo (═O).
In certain embodiments, the ring A is absent.
For example, in certain embodiments, the composition comprises:
In certain embodiments, the ligand compound has structure of
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, (C1-C6)alkyl, (C1-C6)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, (C1-C4)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, (C1-C3)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, (C1-C4)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, (C1-C3)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H, methyl, halo (e.g., Cl), or CN.
In certain embodiments, the ring A is a six membered carbocycle ring that is optionally substituted with R9 and R10.
For example, in certain embodiments, the ligand compound has structure of
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, (C1-C6)alkyl, (C1-C6)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, (C1-C4)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, (C1-C3)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, (C1-C4)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, (C1-C3)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, R6, R9, and R10 are each independently H, methyl, or halo (e.g., Cl).
In certain embodiments, R9, and R10 are absent, the ring A is a six membered carbocycle ring fused (at R7 and R8 position) with a six-membered heteroaryl ring B, and ring B is optionally substituted with one or more substituent selected from the group consisting of (C1-C6)alkyl, (C1-C6)alkoxy, halo, amino, hydroxy, nitro, and CN.
In certain embodiments, the ligand compound has structure of
In certain embodiments, the six-membered heteroaryl ring B is a pyrazine ring, that is fused to carbocycle ring A (at R7 and R8 position).
In certain embodiments, the six-membered heteroaryl ring B is a pyrazine ring substituted with one or more substituent selected from the group consisting of (C1-C6)alkyl, (C1-C6)alkoxy, halo, amino, hydroxy, nitro, and CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, (C1-C6)alkyl, (C1-C6)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, (C1-C4)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, (C1-C3)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, (C1-C4)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, (C1-C3)alkyl, halo, amino, or CN.
In certain embodiments, R1, R2, R3, R4, R5, and R6, are each independently H, methyl, halo (e.g., Cl), or CN.
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound has structure of
A specific value of R is H, or methyl.
A specific value of R is CN.
A specific value of R is halo (e.g., Cl).
A specific value of R is t-butyl.
A specific value of R is methoxy.
A specific value of R is amino or nitro group.
In certain embodiments, each R is independently H, (C1-C4)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, each R is independently H, (C1-C3)alkyl, (C1-C3)alkoxy, halo, amino, hydroxy, nitro, or CN.
In certain embodiments, each R is independently H, (C1-C4)alkyl, halo, amino, or CN.
In certain embodiments, each R is independently H, (C1-C3)alkyl, halo, amino, or CN.
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is selected from the group consisting of
In certain embodiments, the ligand compound is
In certain embodiments, the ligand compound is
In certain embodiments, the composition comprises two or more ligands as described herein.
In certain embodiments, the zero-valent metal is Zn0. In certain embodiments, the zero-valent metal is Fe0. In certain embodiments, the zero-valent metal is Al0. In certain embodiments, the zero-valent metal is Ti0. In certain embodiments, the zero-valent metal is Mg0.
In certain embodiments, the zero-valent metal comprises, or can be provided as, metallic powders or grains.
In certain embodiments, the zero-valent metal comprises, or can be provided as, metallic particles (e.g., nanometer, micrometer, and/or millimeter-sized metallic particles of Zn (Zinc), Fe (iron), Al (aluminum), Ti (titanium), or Mg (magnesium)).
In certain embodiments, the zero-valent metal (e.g., Zn, Fe, Al, Ti, or Mg) comprises nanoparticles having size (e.g., averaged diameter) of less than 1000 nm, for example about 1-999 nm, 20-500 nm, or 40-60 nm. In certain embodiments, the zero-valent metal comprises nanoparticles having size (e.g., averaged diameter) of about 1, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, or 950 nm. In certain embodiments, the zero-valent metal comprises nanoparticles having size (e.g., averaged diameter) of about 5-600, 1-500, 10-90, 20-80, 40-70, 60-80, 10-100, 20-150, 10-200, 20-250, 10-300, 20-350, 10-400, 20-450, 10-500, 20-600, 10-700, 20-800, or 10-900 nm.
In certain embodiments, the zero-valent metal (e.g., Zn, Fe, Al, Ti, or Mg) comprises microparticles having size of less than 1 mm, for example about 1-999 μm). In certain embodiments, the zero-valent metal comprises microparticles having size (e.g., averaged diameter) of about 1, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, or 950 μm. In certain embodiments, the zero-valent metal comprises microparticles having size (e.g., averaged diameter) of about 5-600, 1-500, 10-90, 20-80, 40-70, 60-80, 10-100, 20-150, 10-200, 20-250, 10-300, 20-350, 10-400, 20-450, 10-500, 20-600, 10-700, 20-800, or 10-900 μm.
In certain embodiments, the zero-valent metal (e.g., Zn, Fe, Al, Ti, or Mg) comprises particles having size of less than 1 cm, for example about 1-9.9 mm). In certain embodiments, the zero-valent metal comprises particles having size (e.g., averaged diameter) of about 1, 2, 3, 4, 5, 6, 7, 8, or 9 mm. In certain embodiments, the zero-valent metal comprises particles having size (e.g., averaged diameter) of about 1-9, 2-8, 3-7, 4-9, or 5-8 mm.
In certain embodiments, the ligand binds to the metal (Zn0, Fe0, Al0, Ti0, or Mg0) particle surface. In certain embodiments, the composition comprises ligand coordinated Zn0, Fe0, Al0, Ti0, or Mg0, such as a ligand coordinated or adsorbed on a metal particle surface.
In certain embodiments, the composition is a liquid composition (e.g., aqueous composition).
In certain embodiments, the composition comprises a ligand as described herein at a concentration of about 0.005-0.3, 0.005-0.25, 0.005-0.125, 0.01-0.12, 0.015-0.11, 0.02-0.1, 0.025-0.09, 0.03-0.08, or 0.025-0.25 mM. In certain embodiments, the composition comprises a ligand at a concentration of about 0.005, 0.01, 0.015, 0.02, 0.025, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.125, 0.2, 0.25, or 0.3 mM. In certain embodiments, the composition comprises a ligand at a concentration of about 0.25 mM. In certain embodiments, the composition comprises a ligand at a concentration of about 0.025 mM.
In certain embodiments, the composition comprises metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle as described herein at a concentration of about 1-20, 2-18, 5-15, 5-10, 6-12, 10-16, 5-12.5, or 6-16 mg mL−1. In certain embodiments, the composition comprises metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle as described herein at a concentration of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 mg mL−1. In certain embodiments, the composition comprises metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle as described herein at a concentration of about 5, 10, or 12.5 mg mL−1.
In certain embodiments, the composition has a pH≥7 (e.g., pH≥8, 9, 10, or 11). In certain embodiments, the composition has a pH of about 7. 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5 or 12. In certain embodiments, the composition has a pH of about 7-12, 8-11, 8-10, 8-9, 7-9, 9-10, or 9-11.
In certain embodiments, the composition further comprises ammonium or borate based buffer component or salt. In certain embodiments, the composition further comprises ammonia/ammonium salt buffer component, such as NH4Cl. In certain embodiments, the composition comprises ammonium salt (e.g., NH4Cl, (NH4)2SO4, or ammonium acetate) at a concentration of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 mM. In certain embodiments, the composition comprises ammonium salt (e.g., NH4Cl) at a concentration of about 1-16, 2-12, 3-11, 4-10, or 5-10 mM.
In certain embodiments, the composition is a solid composition (e.g., powder).
In certain embodiments, the composition further comprises a carrier (e.g., porous carrier, such as activated carbon, or porous silica). For example, the carrier media may be blended with the ligand-metal (e.g., ligand-zine, ligand-Fe, ligand-Al, ligand-Ti, or ligand-Mg) composite or serve as support for the ligand-metal composite.
Certain embodiments of the invention provide a method of making a composition as described herein, comprising mixing 1) a zero-valent metal selected from the group consisting of Zn, Fe, Al, Ti, and Mg (zinc, iron, aluminum, titanium, and magnesium); and 2) a ligand compound as described herein.
In certain embodiments, the mixing comprising mixing the zero-valent metal and the ligand compound in a liquid (e.g., an aqueous solution). In certain embodiments, the mixing comprising mixing the zero-valent metal at a concentration (e.g., 5-12.5 mg mL−1) described herein with the ligand compound at a concentration (e.g., 0.025-0.25 mM) described herein.
In certain embodiments, the method further comprises adding ammonium salt (e.g., NH4Cl), for example, to a concentration (e.g., 10 mM) as described herein. In certain embodiments, the method further comprises adjusting the pH of the composition to a pH as described herein (e.g., to pH 9).
In certain embodiments, the method further comprises adding a carrier (e.g., porous carrier, such as activated carbon, or porous silica) to the composition.
In certain embodiments, the method further comprises drying the liquid (e.g., the aqueous solution) to provide a concentrated liquid composition or a solid composition (e.g., powders).
Certain embodiments of the invention provide a device or system as described herein.
In certain embodiments, the device or system is a filtering device or system comprising a composite or composition described herein. For example, a compartment or chamber of the filtering device could be loaded with a composite material or composition as described herein. In certain embodiments, the composition further comprising a carrier such as activated carbon is loaded within a filtering device. In certain embodiments, the composite material or composition may be contained or sandwiched between permeable membranes or meshes. In certain embodiments, a filtering device or system further comprises one or more carrier material(s), such as sand, clay, carbon, resin, plastic beads, glass beads, or a mixture thereof. In certain embodiments, the carrier material(s) may facilitate the immobilization of the metal-ligand composite described herein and provide adequate water conductivity (i.e., allowing the water to penetrate at a desirable rate).
In certain embodiments, the device or system is a reactive barrier comprising a composite or composition described herein (e.g., permeable reactive barrier loaded with metallic particles and organic ligands described herein, which can be used for in situ PFAS groundwater remediation). In certain embodiments, the filtering device is a permeable reactive barrier.
Certain embodiments of the invention provide a method comprising contacting a PFAS compound with a composite, composition or a device or system as described herein.
In certain embodiments, the PFAS compound is a per- or polyfluoroalkyl compound of branched or unbranched, hydrocarbon chain having from 2 to 30 (e.g., 2-16, 7-15, or 8-14) carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), wherein the hydrocarbon chain is substituted on carbon with one or more (e.g., two or more) substituents selected from the group consisting of halo (e.g., F, Cl, Br, and I), carboxyl, and SO3. In certain embodiments, all C—H bonds of the compound are substituted with halo (e.g., all C—F bonds in the compound and no C—H bond). In certain embodiments, at least 90%, 80%, 70%, 60%, 50%, 40%, 30%, 20%, or 10% of all C—H bonds of the compound are substituted with halo (e.g., compound having a plurality of C—F bonds, C—Cl, C—Br, and/or C—I bonds).
In certain embodiments, the PFAS compound is a linear PFAS compound.
In certain embodiments, the PFAS compound is a branched PFAS compound.
In certain embodiments, the PFAS compound is a perfluorocarboxylate compound that has one terminal carboxyl group that is directly linked with the perfluoroalkyl chain.
In certain embodiments, the PFAS compound is a long-chain perfluorocarboxylate compound of CnF2n+1—COO−, wherein n is ≥7 (e.g., n≥8).
In certain embodiments, the PFAS compound is a perfluoroether carboxylate compound (having one or more ether oxygen, such as 1, 2, or 3 —O—).
In certain embodiments, the PFAS compound is a chlorinated polyfluorocarboxylate compound.
In certain embodiments, the PFAS compound is a, branched or unbranched, per- or polyfluoroalkyl compound that comprises sulfonic acid group S(═O)2OH, and wherein one or more of the carbon atoms is optionally replaced by (—O—) and the compound optionally further comprises carboxyl group. In certain embodiments, the PFAS compound is a perfluoroalkylsulfonate compound that has one terminal sulfonic acid group S(═O)2OH that is directly linked with the perfluoroalkyl chain. For example, in certain embodiments, the PFAS compound is perfluorobutanesulfonic acid (PFBS). In certain embodiments, the PFAS compound is perfluorohexanesulfonic acid (PFHxS). In certain embodiments, the PFAS compound is perfluorooctanesulfonic acid (PFOS). In certain embodiments, the PFAS compound is a Nafion byproduct (e.g., Nafion byproduct-2, Nafion byproduct-5, or Nafion byproduct-6).
In certain embodiments, the PFAS compound is contacted at a pH≥7 (e.g., pH≥8, 9, 10, or 11). In certain embodiments, the PFAS compound is contacted at a pH of about 7. 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5 or 12. In certain embodiments, the PFAS compound is contacted at a pH of about 7-12, 8-11, 8-10, 8-9, 7-9, 9-10, or 9-11.
In certain embodiments, the PFAS compound is contacted at a temperature of 10, 20, 30, 40, 50, 60, 70, 80, or 90° C. In certain embodiments, the PFAS compound is contacted at room temperature of about 20-25° C. In certain embodiments, the PFAS compound is contacted without heating. In certain embodiments, the PFAS compound is contacted under heating. In certain embodiments, the PFAS compound is contacted at a temperature of about 40-95, 50-95, 60-90, 70-90, 80-95, or 90-95° C.
In certain embodiments, the PFAS compound is contacted at a metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle concentration of about 1-20, 2-18, 5-15, 5-10, 6-12, 10-16, 5-12.5, or 6-16 mg mL−1. In certain embodiments, the PFAS compound is contacted at a metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle concentration of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 mg mL−1. In certain embodiments, the PFAS compound is contacted at a metal (e.g., Zn0, Fe0, Al0, Ti0, or Mg0) grain or particle concentration of about 5, 10, or 12.5 mg mL−1.
In certain embodiments, the PFAS compound is contacted with a composite or composition described herein at a concentration of Zn0 particles of about 5-12.5 mg/mL.
In certain embodiments, the PFAS compound is contacted with a composite or composition described herein at a concentration of ligand of about 0.005-0.125 mM.
In certain embodiments, the PFAS compound is contacted at a ligand concentration of about 0.005-0.3, 0.005-0.25, 0.005-0.125, 0.01-0.12, 0.015-0.11, 0.02-0.1, 0.025-0.09, 0.03-0.08, or 0.025-0.25 mM. In certain embodiments, the PFAS compound is contacted at a ligand concentration of about 0.005, 0.01, 0.015, 0.02, 0.025, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.125, 0.2, 0.25, or 0.3 mM. In certain embodiments, the PFAS compound is contacted at a ligand concentration of about 0.25 mM. In certain embodiments, the PFAS compound is contacted at a ligand concentration of about 0.025 mM.
In certain embodiments, the PFAS compound is contacted for about at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 16, 20, 24, 36, 48 hours or longer. In certain embodiments, the PFAS compound is contacted for about at least 1-72, 2-48, 3-36, 4-24, 5-20, 6-18, 7-16, 8-12, or 9-10 hours.
In certain embodiments, the method does not comprise contacting the PFAS compound with CoCl2. In certain embodiments, the method further comprises contacting the PFAS compound with CoCl2.
In certain embodiments, the defluorination percentage (deF %) of a contacted PFAS compound is increased by at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, 200% or more by a ligand coordinated metal described herein, as compared to a control, such as a control metal in the absence of the ligand.
In certain embodiments, the defluorination reaction is accelerated or the same defluorination percentage (deF %) of a contacted PFAS compound can be achieved in a time period that is at least 30%, 40%, 50%, 60%, 70%, 80%, or 90% shorter by a ligand coordinated metal described herein, as compared to a control, such as a control metal in the absence of the ligand.
Certain non-limiting, exemplary embodiments include:
Embodiment 1. A composite or composition as described herein.
Embodiment 2. A composite or composition comprising:
Embodiment 3. The composite or composition of Embodiment 2, wherein the ligand compound has structure of
Embodiment 4. The composite or composition of Embodiment 2 or 3, wherein the zero-valent metal is Zn0.
Embodiment 5. The composite or composition of any one of Embodiments 2-4, wherein the zero-valent metal comprises nanoparticles (e.g., nZn0).
Embodiment 6. A device or system comprising the composite or composition of any one of Embodiments 1-5.
Embodiment 7. A method as described herein.
Embodiment 8. A method comprising contacting a PFAS compound with a composite or a composition or a device or a system as described herein.
Embodiment 9. The method of Embodiment 8, wherein the PFAS compound is a linear PFAS compound.
Embodiment 10. The method of Embodiment 8, wherein the PFAS compound is a branched PFAS compound.
Embodiment 11. The method of Embodiment 8, wherein the PFAS compound is a long-chain perfluorocarboxylate compound of CnF2n+1—COO−, wherein n is ≥7 (e.g., n≥8).
Embodiment 12. The method of Embodiment 8, wherein the PFAS compound is a chlorinated polyfluorocarboxylate compound.
Embodiment 13. The method of Embodiment 8, wherein the PFAS compound is a perfluoroether carboxylate compound.
Certain non-limiting, advantageous features include, but not limited to, no need for external energy input (e.g., UV light or electricity), enhanced cost-effectiveness and less expensive than other methods using external energy input (in situ reaction), high efficacy in selectively treating long-chain PFAS, which cannot be removed by current pump-and-treat for groundwater remediation, unique application value for groundwater remediation, such as “permeable reactive barrier”, unique application value for wastewater treatment without using external energy, and easy system construction by blending the ligand-metal (e.g., ligand-zinc) composite with porous media/carrier, etc.
The term “alkyl”, by itself or as part of another substituent, means, unless otherwise stated, a straight or branched chain hydrocarbon radical, having the number of carbon atoms designated (i.e., C1-8 means one to eight carbons). Examples include (C1-C8)alkyl, (C2-C8)alkyl, (C1-C6)alkyl, (C2-C6)alkyl, (C1-C3)alkyl, and (C3-C6)alkyl. Examples of alkyl groups include methyl, ethyl, n-propyl, iso-propyl, n-butyl, t-butyl, iso-butyl, sec-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, and higher homologs and isomers.
The term “alkoxy” refers to the formula —OR or radical thereof, where R is an alkyl as defined.
The term “halo” or “halogen” refers to bromo, chloro, fluoro or iodo. In some embodiments, halogen refers to chloro or fluoro.
The term “cycloalkyl” or “carbocycle” refers to a saturated or partially unsaturated (non-aromatic) all carbon ring having 3 to 8 carbon atoms (i.e., (C3-C8)carbocycle). The term also includes multiple condensed, saturated all carbon ring systems (e.g., ring systems comprising 2, 3 or 4 carbocyclic rings). Accordingly, carbocycle includes multicyclic carbocyles such as a bicyclic carbocycles (e.g., bicyclic carbocycles having about 3 to 15 carbon atoms, about 6 to 15 carbon atoms, or 6 to 12 carbon atoms such as bicyclo[3.1.0]hexane and bicyclo[2.1.1]hexane), and polycyclic carbocycles (e.g tricyclic and tetracyclic carbocycles with up to about 20 carbon atoms). The rings of the multiple condensed ring system can be connected to each other via fused, spiro and bridged bonds when allowed by valency requirements. For example, multicyclic carbocyles can be connected to each other via a single carbon atom to form a spiro connection (e.g., spiropentane, spiro[4,5]decane, etc), via two adjacent carbon atoms to form a fused connection (e.g., carbocycles such as decahydronaphthalene, norsabinane, norcarane) or via two non-adjacent carbon atoms to form a bridged connection (e.g., norbornane, bicyclo[2.2.2]octane, etc). Non-limiting examples of cycloalkyls include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, bicyclo[2.2.1]heptane, pinane, and adamantane. In certain embodiments, the carbocycle is a C6 carbocycle.
The term “aryl” as used herein refers to a single all carbon aromatic ring or a multiple condensed all carbon ring system wherein at least one of the rings is aromatic. For example, in certain embodiments, an aryl group has 6 to 20 carbon atoms, 6 to 14 carbon atoms, 6 to 12 carbon atoms, or 6 to 10 carbon atoms. Aryl includes a phenyl radical. Aryl also includes multiple condensed carbon ring systems (e.g., ring systems comprising 2, 3 or 4 rings) having about 9 to 20 carbon atoms in which at least one ring is aromatic and wherein the other rings may be aromatic or not aromatic (i.e., cycloalkyl). The rings of the multiple condensed ring system can be connected to each other via fused, spiro and bridged bonds when allowed by valency requirements. It is to be understood that the point of attachment of a multiple condensed ring system, as defined above, can be at any position of the ring system including an aromatic or a carbocycle portion of the ring. Non-limiting examples of aryl groups include, but are not limited to, phenyl, indenyl, indanyl, naphthyl, 1, 2, 3, 4-tetrahydronaphthyl, anthracenyl, and the like.
The term “heterocycle” or “heterocycloalkyl” refers to a single saturated or partially unsaturated ring that has at least one atom other than carbon in the ring, wherein the atom is selected from the group consisting of oxygen, nitrogen and sulfur; the term also includes multiple condensed ring systems that have at least one such saturated or partially unsaturated ring, which multiple condensed ring systems are further described below. Thus, the term includes single saturated or partially unsaturated rings (e.g., 3, 4, 5, 6 or 7-membered rings) from about 1 to 6 carbon atoms and from about 1 to 3 heteroatoms selected from the group consisting of oxygen, nitrogen and sulfur in the ring. The sulfur and nitrogen atoms may also be present in their oxidized forms. Exemplary heterocycles include but are not limited to azetidinyl, tetrahydrofuranyl and piperidinyl. The term “heterocycle” or “heterocycloalkyl” also includes multiple condensed ring systems (e.g., ring systems comprising 2, 3 or 4 rings) wherein a single heterocycle ring (as defined above) can be condensed with one or more groups selected from cycloalkyl, aryl, and heterocycle to form the multiple condensed ring system. The rings of the multiple condensed ring system can be connected to each other via fused, spiro and bridged bonds when allowed by valency requirements. It is to be understood that the individual rings of the multiple condensed ring system may be connected in any order relative to one another. It is also to be understood that the point of attachment of a multiple condensed ring system (as defined above for a heterocycle) can be at any position of the multiple condensed ring system including a heterocycle, aryl and carbocycle portion of the ring. In one embodiment the term heterocycle includes a 3-15 membered heterocycle. In one embodiment the term heterocycle includes a 3-10 membered heterocycle. In one embodiment the term heterocycle includes a 3-8 membered heterocycle. In one embodiment the term heterocycle includes a 3-7 membered heterocycle. In one embodiment the term heterocycle includes a 3-6 membered heterocycle. In one embodiment the term heterocycle includes a 4-6 membered heterocycle. In one embodiment the term heterocycle includes a 3-10 membered monocyclic or bicyclic heterocycle comprising 1 to 4 heteroatoms. In one embodiment the term heterocycle includes a 3-8 membered monocyclic or bicyclic heterocycle heterocycle comprising 1 to 3 heteroatoms. In one embodiment the term heterocycle includes a 3-6 membered monocyclic heterocycle comprising 1 to 2 heteroatoms. In one embodiment the term heterocycle includes a 4-6 membered monocyclic heterocycle comprising 1 to 2 heteroatoms. Exemplary heterocycles include, but are not limited to aziridinyl, azetidinyl, pyrrolidinyl, piperidinyl, homopiperidinyl, morpholinyl, thiomorpholinyl, piperazinyl, tetrahydrofuranyl, dihydrooxazolyl, tetrahydropyranyl, tetrahydrothiopyranyl, 1,2,3,4-tetrahydroquinolyl, benzoxazinyl, dihydrooxazolyl, chromanyl, 1,2-dihydropyridinyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 1,4-benzodioxanyl, spiro[cyclopropane-1,1′-isoindolinyl]-3′-one, isoindolinyl-1-one, 2-oxa-6-azaspiro[3.3]heptanyl, imidazolidin-2-one imidazolidine, pyrazolidine, butyrolactam, valerolactam, imidazolidinone, hydantoin, dioxolane, phthalimide, and 1,4-dioxane.
The term “heteroaryl” as used herein refers to a single aromatic ring that has at least one atom other than carbon in the ring, wherein the atom is selected from the group consisting of oxygen, nitrogen and sulfur; “heteroaryl” also includes multiple condensed ring systems that have at least one such aromatic ring, which multiple condensed ring systems are further described below. Thus, “heteroaryl” includes single aromatic rings of from about 1 to 6 carbon atoms and about 1-4 heteroatoms selected from the group consisting of oxygen, nitrogen and sulfur. The sulfur and nitrogen atoms may also be present in an oxidized form provided the ring is aromatic. Exemplary heteroaryl ring systems include but are not limited to pyridyl, pyrimidinyl, oxazolyl or furyl. “Heteroaryl” also includes multiple condensed ring systems (e.g., ring systems comprising 2, 3 or 4 rings) wherein a heteroaryl group, as defined above, is condensed with one or more rings selected from cycloalkyl, aryl, heterocycle, and heteroaryl. It is to be understood that the point of attachment for a heteroaryl or heteroaryl multiple condensed ring system can be at any suitable atom of the heteroaryl or heteroaryl multiple condensed ring system including a carbon atom and a heteroatom (e.g., a nitrogen). Exemplary heteroaryls include but are not limited to pyridyl, pyrrolyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrazolyl, thienyl, indolyl, imidazolyl, triazolyl, tetrazolyl, oxazolyl, isoxazolyl, thiazolyl, furyl, oxadiazolyl, thiadiazolyl, quinolyl, isoquinolyl, benzothiazolyl, benzoxazolyl, indazolyl, quinoxalyl, and quinazolyl.
Certain non-limiting embodiments are further illustrated by the Example below:
This study explores the ligand-enabled reductive defluorination of per- and polyfluoroalkyl substances (PFAS) by metallic zinc. Adding a N,N-bidentate ligand, 4,4′-dimethyl-2,2′-bipyridine (Me2bpy), to nano-sized zinc powder (nZn0) enabled rapid and significant defluorination from linear long-chain perfluorocarboxylates (CnF2n+1—COO−) and perfluoroether carboxylates (CxF2x+1—O—CyF2y—COO−) that did not degrade in the cobalt (e.g., vitamin B12)-catalyzed systems. The heterogeneous nature of reductive PFAS defluorination by nZn0 was confirmed by comparison among diverse PFAS substrates and with the homogeneous UV-sulfite system. The examined PFAS substrates include CnF2n+1—COO−, −OOC—CnF2n—COO−, CnF2n+1—CH2CH2—COO−, CnF2n+1—SO3−, CxF2x+1—O—CyF2y—COO−, and Cl—(CF2CFCl)n—CF2COO− of various chain lengths and linear/branch patterns. The results provide mechanistic insights into designing and understanding heterogeneous reaction systems for PFAS degradation. This study also demonstrates the critical role of organic ligands in enhancing the reactivity of metallic nanoparticles for potential in situ PFAS remediation, highlighting the environmental significance of coordination chemistry.
The urgent demand for the degradation of per- and polyfluoroalkyl substances (PFAS) in the global water environment has led to flourishing technology innovations in the past two decades. The majority of engineering approaches use energetic inputs such as hydrothermal,1-3 ultraviolet light,4-11 plasma,12-15 electricity,16-19 ultrasonication,20,21 and even gamma ray22-24 to cleave the strong C—F bonds. In many systems, hydrated electrons, hydroxyl radicals, and semiconductor holes are the primary reactive species. However, PFAS destruction does not necessarily require “advanced” redox reactive species or reaction conditions. For example, using NaOH in water/DMSO mixed solvent achieved defluorination of perfluorocarboxylates (PFCAs, n=1-8 CnF2n+1—COO−) and GenX (C3F7—O—CF(CF3)—COO−) at 40-120° C.25, 26 “Traditional” chemical systems were generally considered ineffective for PFAS destruction, although might worth further re-investigation.
In 2008, Ochoa-Herrea et al.27 reported B12 (a corrin-CoIII complex,
While the above results have persuaded engineering practices to adopt “advanced” reaction systems to degrade common PFAS pollutants, the biomimetic design might be an alternative route to overcoming kinetic barriers and obtaining novel functions.34, 35 Enzymatic metal complexes such as B12, chlorophyll (chlorin-Mg), heme (porphyrin-Fe), and Mo cofactor (pyranopterin-dithiolate-Mo,
Because the property tuning of anionic N,N,N,N-tetradentate ligands in Co complexes is challenging (e.g., limited locations for structural modification, tedious synthesis, and low solubility),52-54 we sought to yield similar functions of the porphyrin-Co complexes by mixing N,N-bidentate (R)2bpy ligands with CoCl2 (
Chemicals. The nano-sized Zn0 powder was purchased from SkySpring Nanomaterials (9920XH, 99.7%, 40-60 nm)30 and used as received. Additional details of the R2bpy ligands, PFAS substrates, inorganic chemicals, and the preparation of stock solutions are also provided in the Supporting Information (SI) section below.
Reactions. All reactions were conducted in an anaerobic glove bag (Coy Laboratories, 95% N2 and 5% H2). For a typical reaction, a 15 mL round-bottom flask was loaded with 10 mL of an aqueous suspension containing individual PFAS (0.1 mM), nZn0 (10 mg mL−1), Me2bpy (0.025 mM), and NH4Cl buffer (10 mM, pH adjusted to 9.0). The flask was sealed with a rubber stopper (penetrated with a 22-gauge needle as the H2 outlet) and heated with 240 rpm magnetic stirring at 90° C. in a silicone oil bath. At designated reaction times, 1 mL of the suspension was collected and centrifuged at 12000 rpm to obtain the clear aqueous phase for further analysis.
Sample Analyses. The fluoride ion (F−) was measured by an ion-selective electrode (ISE, Fisherbrand Accumet) with a Thermo Scientific Orion Versa Star Pro meter. Unlike TiIII-citrate,28 nZn0 did not interfere with the ISE measurement. Transformation products of selected PFAS were analyzed by liquid chromatography equipped with a high-resolution quadrupole orbitrap mass spectrometer (LC-HRMS/MS) (Q Exactive, Thermo Fisher Scientific) following established protocols.64 Scanning transmission electron microscopy (STEM) characterization was conducted for both pristine and used nZn0. Further technical details are described in the SI.
Ligand-Enhanced Zn0 Reduction System. In the beginning, we added H2bpy to the mixture of CoCl2 and nZn0 for the defluorination of perfluoro-3,7-dimethyloctanoic acid (PF-3,7-Me2OA). The H2bpy+CoCl2+nZn0 combination yielded 2.4% of defluorination percentage (deF %), much lower than using corrin-Co and porphyrin-Co in the first 24 h (Table 1, entry 1 versus 11 and 12). However, the deF % by the control setting (H2bpy+nZn0, no CoCl2) surprisingly reached 36.6%. Further screening of various R2bpy ligands confirmed superior performance by nZn0 without CoCl2. The deF % by Me2bpy+nZn0 (Table 1, entry 2) exceeded those by corrin-Co and porphyrin-Co. Interestingly, the effect of R2bpy ligands did not follow the trend of Hammett constants of R (Table 1, entries 1, 2, and 5). Moreover, Cl2bpy resulted in very similar deF % as H2bpy (Table 1, entry 9 versus 1), probably due to the rapid reductive dechlorination by nZn0.65 The nZn0 reduction of nitro group66 could also explain the similar deF % by using (NO2)2bpy and (NH2)2bpy (Table 1, entry 8 versus 6). In addition, mixing 1-3 equivalents of Me2bpy with ZnCl2 and citrate-TiIII (as a potential bulk reductant) resulted in no defluorination.
aReaction conditions: PF-3,7-Me2OA (0.1 mM), nZn0 (5 mg/mL−1), individual ligand (0.25 mM), NH4Cl (10 mM), CoCl2 (0.125 mM, if added), initial pH 9.0, and 70° C. Errors indicate the standard deviation of triplicate reactions.
We used Me2bpy to sequentially optimize the dose of nZn0 (10 mg mL−1), the concentration of Me2bpy (0.025 mM, one-tenth of the original level), temperature (90° C.), and pH (9.0) for the treatment of 0.1 mM PF-3,7-Me2OA (
The use of borate (pKa=9.23) as pH buffer yielded only 59% of defluorination, while those using ammonium buffers (pKa=9.25) with Cl−, SO42−, and CH3COO− counter anions reached 80-83%. Borate is known for passivating Zn solid surface.67 The optimized loading of nZn0 (10 g L−1, equivalent to 154 mM if “dissolved”) far exceeded PF-3,7-Me2OA (0.1 mM). Hence, it appears that the reaction involved Zn0 below the outmost surface layer. Because nZn0 reacts with water and produces H2, the reaction stoichiometry could not be established between dissolved Zn2+ and released F−. The ligand concentration (0.025 mM) is lower than the parent PF-3,7-Me2OA (0.1 mM) and released F− (up to 1.6 mM). Hence, the Me2bpy ligand acted as a catalyst, whereas nZn0 served as the bulk reductant. The most probable reaction scheme is that Me2bpy binds to a Zn0 atom on the particle surface (see below for the heterogeneous nature of the reaction) and facilitates the reductive C—F cleavage. The addition of CoCl2 competed for the ligand, thus resulting in a much lower deF % (Table 1). However, the ligand/metal stoichiometry and the coordination structure of the Me2bpy-Zn0 complex remain elusive. In addition, the -Me substitution was superior to both —H and —OMe, whereas —OH and —NH2 allowed unexpectedly low defluorination. Therefore, the binding pattern for all R2bpy ligands coordinating with the surface Zn0 is probably variable. The structure-activity relationship for the R2bpy ligands is different from another Mo-catalyzed heterogeneous system for aqueous perchlorate reduction, where (NH2)2bpy outperformed all other ligands, including Me2bpy.50
Defluorination of Various PFAS by Me2bpy-Zn0. In view of the high activity of Me2bpy-Zn0 in PF-3,7-Me2OA defluorination, we examined the reactivity with linear perfluorocarboxylates (PFCAs), which did not degrade in either Co—Zn0 or Co—TiIII systems.28, 30 Surprisingly, PFOA (C7F15—COO−) showed 6.9% of defluorination within 4 h (
−OOC—C6F12—COO−
−OOC—C8F16—COO−
aReaction conditions: individual PFAS (0.1 mM), nZn0 powder (10 mg/mL−1), Me2bpy (0.025 mM), NH4Cl (10 mM), initial pH 9.0, 90° C., 8 h.
bTime profiles at both 90° C. and 20° C. are shown in FIG. 2.
We hypothesized that the long fluoroalkyl chain (containing weak C—F bonds,
However, the hydrophobicity of PFAS might be another contributing factor. When the terminal CF3 in C9F19—COO− was replaced by another carboxylate (—COO—C8F16—COO PFdiCA,
An earlier study found that the chlorinated polyfluorocarboxylate, Cl4-PFOA (structure shown in Table 2, entry 23), could react with acid-treated 30-mesh (<600 μm) Zn0 grains at room temperature and release up to four F from each Cl4-PFOA molecule in 5 days.33 We used nZn0 powder (20-500 nm,
In addition to the bipyridine ligands, certain triple-ring ligands, such as 1,10-Phenanthroline ligands, were also investigated (see Table 3) in this Example 1, and showed similar or superior performance as compared to Me2bpy.
aReaction conditions: PFDA (0.1 mM), nZn0 powder (10 mg mL−1), individual ligand (0.025 mM), NH4Cl (10 mM), initial pH 9.0, 90° C., 4 h.
bThe deF % value is less than earlier results due to the aging and slow oxidation of the same batch of nZn0 powder. However, all data in this table 3 were produced in the same batch, so direct comparison among these ligands is valid. Significantly higher deF % values are expected with freshly made nZn0 powder in the same or different sizes.
Mechanistic Insights. Beyond confirming the heterogeneous nature of the reaction system, our current experimental approaches cannot probe more detailed information at the molecular level.
Nevertheless, the outstanding performance by Me2bpy among various R2bpy ligands (without following the trend of Hammett constants) may indicate the complexity of the R2bpy-Zn coordination pattern. Moreover, the primary role of Me2bpy is likely not to enhance the mass transfer of PFAS to the nZn0 surface. First, the initial probe, PF-3,7-Me2PFOA, is a highly hydrophobic structure and thus strongly favors aggregation at the heterogeneous interface. But the control experiment without ligand yielded negligible defluorination (Table 1, entry 10). In comparison, Cl4-PFOA was completely defluorinated at the nZn0 surface without Me2bpy. Second, adding octadecyltrimethylammonium chloride (C18TMAC), a cationic surfactant used for enhancing the mass transfer of “high-solubility” anionic PFAS to the reactive water-gas interface,71 did not increase the deF % of PFOA by Me2bpy-Zn0 (5.3%, versus 6.9% without C18TMAC).
In earlier studies on B12-catalyzed dechlorination of sp3 C—Cl bonds in CCl4 and ClCH2CN, mechanisms with various differences in subtle details were proposed. In general, (L)Co1 could attack the C—Cl bond and yield (L)CoIII—C and Cl−.72 When (L)CoII was the catalytic center, the single electron transfer converted the C—Cl into a C· radical and Cl−.73, 74 Because ZnII is not reductive and Zn1 is rare,75 the most probable reaction species is Me2bpy-coordinated Zn0. However, C8F17—COO−, C8F17—CH2CH2—COO−, and C8F17—SO3 all contain weak C—F bonds (
C—F+2eaq−+H+→C—H+F− (1)
C—F+[ligand-Zn0]+H+→C—H+F−+[ligand-Zn2+] (2)
Further comparison of deF % values for various PFAS by Me2bpy-Zn0 and UV/sulfite68, 69 also found high similarities for the long-chain PFAS (
Implications for Environmental Remediation. The Me2bpy ligand surprisingly led to reductive defluorination from linear PFCAs and PFECAs by nZn0. Together with the smaller metallic particles and elevated temperature, the addition of Me2bpy shortened the half-life of “the first reductive defluorination step for PFOA” from the model-predicted 7 years33 to the experimentally observed 4 hours. The current Me2bpy-Zn0 system may not fully satisfy all the requirements of PFAS degradation in certain polluted water samples, particularly for (i) limited reactivity toward short-chain PFAS and (ii) limited reactivity toward PFSAs and FTCAs. Extension of the PFAS substrate scope is urgent for many recently reported technologies that only demonstrated the efficacy toward PFOA. For the ligand-nZn0 system, we emphasize the high promise of coordination chemistry to further enhance intrinsic reactivity (and other approaches to enhance mass transfer of short-chain PFAS).
The use of Zn0 for environmental remediation has been explored for chlorinated organic pollutants.33,60-62 This study shows that specific organic ligands could add or enhance the reactivity of Zn0 with fluorinated chemicals. The current “selectivity” toward long-chain PFAS has a significant value for in situ groundwater or soil remediation. Long-chain PFAS are highly hydrophobic, strongly bind to soil organics, and thus cannot be effectively cleaned via the ex situ pump-and-treat strategy.77, 78 In multiple surface soil samples of the U.S. East Coast region, the n=8-11 CnF2n+1—COO took more than 50% of the total PFCAs.79 Chlorine-containing PFAS, which have much higher reactivity with Zn0 than perfluorinated counterparts, have also been confirmed as widespread soil pollutants.80-82 Hence, a reactive barrier loaded with metallic particles and organic ligands may be a viable technical solution for in situ PFAS remediation.
PFAS chemicals were purchased from Oakwood Chemicals (OC), Apollo Scientific (AS), Manchester Organics (MO), and SynQuest Laboratories (SQ). Table A1 summarizes the name, purity, and CAS number.
Stock solutions were prepared with degassed solvents in an anaerobic glove bag (95% N2 and 5% H2 atmosphere; Coy Laboratories). PFASs were dissolved in methanol as 15 mM stock solutions. Substituted 2,2′-bipyridine ligands were dissolved in ethanol as 5 mM stock solutions. CoCl2 was dissolved in DI water as 5 mM stock solution. Ammonia-ammonium buffer was prepared by dissolving 107.0 mg NH4Cl in a 200 mL DI water, followed by adding 0.1 M NaOH solution until the pH reached 9.0.
All samples were diluted by 10 times and centrifuged at 12000 rpm before dilution for MS analysis.
Zn particles after reaction were filtered by DI water, and dried at 90° C. in the glove bag before the characterization by a scanning transmission electron microscope (STEM, FEI Titan Themis 300) equipped with an energy dispersive X-ray spectrometer (EDS) system at 300 kV accelerating voltage. STEM images were acquired with a high-angle annular dark-field (HAADF) detector.
Our attempts found that energy-dispersive X-ray (EDX) elemental analysis might be unsuitable for characterizing either Me2bpy or PFAS adsorbed on the nZn0 surface. The thin organic layer could emit negligible signal compared to the bulk non-porous Zn particles.
All publications, patents, and patent documents are incorporated by reference herein, as though individually incorporated by reference. The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention.
This application claims priority to U.S. Provisional Application No. 63/543,654 that was filed on Oct. 11, 2023. The entire content of the application referenced above is hereby incorporated by reference herein.
This invention was made with government support under 1709719 awarded by the National Science Foundation. The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
63543654 | Oct 2023 | US |